Retrograde reperfusion of renal grafts to reduce ischemic-reperfusion injury
- PMID: 36704809
- PMCID: PMC9832596
- DOI: 10.4285/kjt.22.0053
Retrograde reperfusion of renal grafts to reduce ischemic-reperfusion injury
Abstract
Background: During transplantation, a kidney graft undergoes a cascade of pathological changes, referred to as ischemia-reperfusion injury (IRI), as it is incorporated into the bloodstream. Various studies have reported that retrograde reperfusion (RRP) leads to improved myocardial recovery and could reduce IRI in liver transplantation. This study investigated the effect of RRP in renal transplantation with a focus on reduction of kidney IRI.
Methods: Between December 2019 and July 2022, 15 consecutive kidney transplants were performed with retrograde venous reperfusion. To conduct a comparative study and to recruit a control group, 15 kidney transplants that had been performed in the same center by the same two surgeons were retrospectively analyzed. Differences between the two groups were considered statistically significant at P<0.05.
Results: The baseline characteristics of the two groups were statistically comparable (P>0.05). The surgical technique for kidney transplantation was the same in both groups. On the first postoperative day, polyuria was less pronounced in the RRP group (P<0.01). Serum creatinine and urea levels and estimated glomerular filtration rates on postoperative days 1, 4, 7, and 30 were lower in the RRP group (P<0.05).
Conclusions: Retrograde venous reperfusion of a kidney transplant, preceding antegrade arterial reperfusion, reduced the effects of renal parenchyma IRI. To validate the results of this study, it is necessary to conduct further studies on a larger cohort of patients with a longer follow-up period.
Keywords: Injuries; Ischemia reperfusion; Kidney transplantation.
© 2022 The Korean Society for Transplantation.
Conflict of interest statement
Conflict of Interest No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.BJU Int. 2012 Dec;110(11 Pt C):E1187-95. doi: 10.1111/j.1464-410X.2012.11526.x. Epub 2012 Nov 16. BJU Int. 2012. PMID: 23157304
-
Sodium thiosulfate-supplemented UW solution protects renal grafts against prolonged cold ischemia-reperfusion injury in a murine model of syngeneic kidney transplantation.Biomed Pharmacother. 2022 Jan;145:112435. doi: 10.1016/j.biopha.2021.112435. Epub 2021 Nov 17. Biomed Pharmacother. 2022. PMID: 34798469
-
Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial.J Surg Res. 2014 May 1;188(1):303-8. doi: 10.1016/j.jss.2013.06.058. Epub 2013 Jul 22. J Surg Res. 2014. PMID: 24556231 Clinical Trial.
-
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation.Nephrol Dial Transplant. 2007 Sep;22 Suppl 8:viii54-viii60. doi: 10.1093/ndt/gfm651. Nephrol Dial Transplant. 2007. PMID: 17890265 Review.
-
The Optimization of Renal Graft Preservation Temperature to Mitigate Cold Ischemia-Reperfusion Injury in Kidney Transplantation.Int J Mol Sci. 2022 Dec 29;24(1):567. doi: 10.3390/ijms24010567. Int J Mol Sci. 2022. PMID: 36614006 Free PMC article. Review.
Cited by
-
Comprehensive Overview of Innovative Strategies in Preventing Renal Ischemia-reperfusion Injury: Insights from Bibliometric and In silico Analyses.Curr Pharm Des. 2024;30(20):1578-1598. doi: 10.2174/0113816128283420240409050754. Curr Pharm Des. 2024. PMID: 38676525 Review.
References
-
- Asgeirsdóttir TL, Asmundsdóttir G, Heimisdóttir M, Jónsson E, Pálsson R. Cost-effectiveness analysis of treatment for end-stage renal disease. Laeknabladid. 2009;95:747–53. - PubMed
LinkOut - more resources
Full Text Sources